Key Metrics
CiteScore 

4.1
H-Index 

29
Impact Factor 

< 5
SJR 

Q1Rheumatology

SNIP 

1.31
Recommended pre-submission checks
Powered by 

Topics Covered on Rheumatology and Therapy
Rheumatology and Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 5500 | USD 6850 | GBP 4700 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Rheumatology and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Rheumatology and Therapy
Cutaneous Manifestations in Psoriatic Arthritis: Phenotypes, Clinical Burden, and Therapeutic Implications.
- 18 May 2026
- Rheumatology and therapy
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).
- 16 May 2026
- Rheumatology and therapy
Hydroxychloroquine as an Adjunct Therapy for Secondary Thrombosis Prevention in Primary Antiphospholipid Syndrome: A Systematic Review and Meta-analysis.
- 9 May 2026
- Rheumatology and therapy
Golimumab for the Treatment of Rheumatoid Arthritis: A Narrative Review of Pivotal Randomized Trials and Real-World Studies.
- 5 May 2026
- Rheumatology and therapy
Prospective Quantification of Glucocorticoid Toxicity Across Dosage Ranges in Systemic Lupus Erythematosus: Insights from the Glucocorticoid Toxicity Index.
- 28 Apr 2026
- Rheumatology and therapy
Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study.
- 21 Apr 2026
- Rheumatology and therapy
Cutaneous Manifestations in Psoriatic Arthritis: Phenotypes, Clinical Burden, and Therapeutic Implications.
- 18 May 2026
- Rheumatology and therapy
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).
- 16 May 2026
- Rheumatology and therapy
Hydroxychloroquine as an Adjunct Therapy for Secondary Thrombosis Prevention in Primary Antiphospholipid Syndrome: A Systematic Review and Meta-analysis.
- 9 May 2026
- Rheumatology and therapy
Golimumab for the Treatment of Rheumatoid Arthritis: A Narrative Review of Pivotal Randomized Trials and Real-World Studies.
- 5 May 2026
- Rheumatology and therapy
Prospective Quantification of Glucocorticoid Toxicity Across Dosage Ranges in Systemic Lupus Erythematosus: Insights from the Glucocorticoid Toxicity Index.
- 28 Apr 2026
- Rheumatology and therapy
Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study.
- 21 Apr 2026
- Rheumatology and therapy